References
- Hollingsworth RE, Jansen K. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines. 2019;4:7.
- Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med. 1998;4(3):328–332.
- Sauter B, Albert ML, Francisco L, et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 2000;191(3):423–434.
- Miles AP, Saul A. Extraction and characterization of vaccine antigens from water-in-oil adjuvant formulations. Methods Mol Biol. 2005;308:293–300.
- Yamanaka M, Hiramatsu K, Hirahara T, et al. Pathological studies on local tissue reactions in guinea pigs and rats caused by four different adjuvants. J Vet Med Sci. 1992;54(4):685–692.
- Leenaars PPAM, Koedam MA, Wester PW, et al. Assessment of side effects induced by injection of different adjuvant/antigen combinations in rabbits and mice. Lab Anim. 1998;32(4):387–406.
- Estevez F, Carr A, Solorzano L, et al. Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP). Vaccine. 1999;18(1–2):190–197.
- Mesa C, de León J, Fernández LE. Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for generation of CTL responses to peptide and protein antigens. Vaccine. 2006;24(14):2692–2699.
- Ramírez BS, Pestana ES, Hidalgo GG, et al. Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant. Int J Cancer. 2006;119(9):2190–2199.
- Bada AM, Iglesias A, Arteaga ME, et al. Non-clinical immuno-toxicological evaluation of the HER-1 cancer vaccine in Non-Human Primates: a 12-month study. Vaccine. 2006;31:89–95.
- Alpízar YA, Ramírez BS, Hernández DR, et al. HER1-ECD vaccination dispenses with emulsification to elicit HER1-specific anti-proliferative effects. Hum Vaccin. 2009;5(3):158–158.
- World Health Organization (WHO). WHO guidelines on nonclinical evaluation of vaccines. WHO Technical Report Series 927. World Health Organization (WHO); 2005.
- Gad SC. Animal models in toxicology. 3rd ed. CRC press, Taylor & Francis Group; 2016.
- Casacó A, Beausoleil I, Gonzalez B, et al. Hematological, biochemical, respiratory, cardiovascular and electroneurophysiological parameters in African green monkeys (Cercopithecus aethiops sabaeus). Its use in non-clinical toxicological studies. J Med Primatol. 2010;39(3):177–186.
- Mancebo A, Casacó A, González B, et al. Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity. Vaccine. 2012;30(22):3329–3338.
- Mancebo A, Casacó A, Sánchez B, et al. Repeated dose (14 days) rat intramuscular toxicology study of HER1 vaccine. Regul Toxicol Pharmacol. 2012;64(3):425–434.
- Bada AM, Iglesias A, León A, et al. Non-clinical immuno-toxicological evaluation of HER1 cancer vaccine in non-human primates: a 12-month study. Vaccine. 2012;31:89–95.
- Centre de Recherches Biologiques. CERB REPORT 20050623TRB. Montanide ISA 51 VG. 18-week intramuscular toxicity study in rats. Baugy, September 18; 2006.
- Rosenberg SA, Yang JC, Kammula US, et al. Different adjuvanticity of incomplete freund's adjuvant derived from beef or vegetable components in melanoma patients immunized with a peptide vaccine. J Immunother. 2010;33(6):626–629.
- Springer DA, Baker KC. Effect of ketamine anesthesia on daily food intake in Macaca mulatta and Cercopithecus aethiops. Am J Primatol. 2007;69(10):1080–1092.
- Arteaga ME, Maceira M, Casacó A, et al. Multiple dose toxicity study of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 intravenously administered to Cercopithecus aethiops sabaeus monkeys. Hum Exp Toxicol. 2004;23(5):219–227.
- Kolka MA, Elizondo RS, Weinberg RP. Sympathoadrenal responses to cold and ketamine anesthesia in the rhesus monkey. J Appl Physiol Respir Environ Exerc Physiol. 1983;54(4):896–900.
- Gosling P. Albumin and the critically ill. Care Crit Ill. 1995;11:57–61.
- Doweiko JP, Nompleggi DJ. The role of albumin in human physiology and pathophysiology, part III: albumin and disease states. JPEN J Parenter Enteral Nutr. 1991;15(4):476–483.
- Bennett JS, Gossett KA, McCarthy MP, et al. Effects of ketamine hydrochloride on serum biochemical and hematologic variables in rhesus monkeys (Macaca mulatta). Vet Clin Pathol. 1992;21(1):15–18.
- Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437.
- Seifter J, Aronson P. Properties and physiologic roles of the plasma membrane sodium-hydrogen exchanger. J Clin Invest. 1986;78(4):859–864.
- Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358(11):1160–1174.
- Ramírez BS, Alpízar YA, Fernández DRH, et al. Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine. Vaccine. 2008;26(38):4918–4926.,
- Fuentes D, Chacón L, Casacó A, et al. Effects of an epidermal growth factor receptor-based cancer vaccine on wound healing and inflammation processes in murine experimental models. Int Wound J. 2014;11(1):98–103.